Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Frailty and Oxygen-ozone Therapy: Integrated Approach to Identify Biological and Neuropsychological Markers

NCT06071611 is registered in ClinicalTrials.gov with IRCCS Centro San Giovanni di Dio Fatebenefratelli as lead sponsor.

NCT NCT06071611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06071611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Frailty and Oxygen-ozone Therapy: Integrated Approach to Identify Biological and Neuropsychological Markers
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase
Not applicable
Overall status
Completed
Start date
July 2, 2019
Completion date
November 17, 2023
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive frailty